Danske Bank A S Sells 102,811 Shares of GE HealthCare Technologies Inc. $GEHC

Key Points

• Danske Bank trimmed its stake in GE HealthCare by 32.1%, selling 102,811 shares and leaving it with 217,356 shares valued at about $17.83 million at quarter-end.
• Company insiders increased positions — CEO Peter Arduini bought 4,169 shares at $59.92 and director Frank Jimenez bought 1,750 shares — suggesting management confidence despite recent headwinds.
• Guidance and results: GE HealthCare cut FY26 EPS guidance to $4.80–5.00 after a Q1 that saw revenue beat but an EPS miss and margin pressure, prompting analyst price‑target cuts and downgrades.

Danske Bank A S lessened its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 32.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 217,356 shares of the company's stock after selling 102,811 shares during the period. Danske Bank A S's holdings in GE HealthCare Technologies were worth $17,828,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in the stock. Citizens Financial Group Inc. RI lifted its stake in shares of GE HealthCare Technologies by 6.4% in the fourth quarter. Citizens Financial Group Inc. RI now owns 5,647 shares of the company's stock valued at $463,000 after buying an additional 340 shares during the period. Laurel Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at about $26,000. US Bancorp DE lifted its stake in shares of GE HealthCare Technologies by 4.9% in the fourth quarter. US Bancorp DE now owns 336,447 shares of the company's stock valued at $27,595,000 after buying an additional 15,861 shares during the period. Kohmann Bosshard Financial Services LLC bought a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at about $38,000. Finally, AMG National Trust Bank bought a new stake in shares of GE HealthCare Technologies in the fourth quarter valued at about $1,086,000. Institutional investors own 82.06% of the company's stock.

Insider Activity

In other news, CEO Peter J. Arduini bought 4,169 shares of the business's stock in a transaction dated Thursday, April 30th. The stock was bought at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the purchase, the chief executive officer owned 259,424 shares of the company's stock, valued at approximately $15,544,686.08. The trade was a 1.63% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Frank R. Jimenez bought 1,750 shares of the business's stock in a transaction dated Thursday, April 30th. The stock was purchased at an average price of $60.45 per share, with a total value of $105,787.50. Following the purchase, the insider directly owned 93,932 shares of the company's stock, valued at $5,678,189.40. The trade was a 1.90% increase in their position. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders bought 9,229 shares of company stock worth $556,180. Insiders own 0.36% of the company's stock.

GE HealthCare Technologies News Summary

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Insiders are buying shares — CEO Peter Arduini, CFO James Saccaro and director Frank R. Jimenez increased positions (multiple Form 4 filings), which investors often interpret as management confidence in the company’s outlook. Read More. • Read More. • Read More.
• Positive Sentiment: Heavy call-option buying — an unusual surge in call volume suggests short-term bullish/speculative interest that can amplify upside moves. (No article link available)
• Neutral Sentiment: Wells Fargo lowered its price target to $75 but kept an overweight rating, signaling upside exists vs. current levels while tempering near-term expectations. Read More.
• Neutral Sentiment: Operational changes — GEHC announced a reorganization (Imaging + Advanced Visualization) and executive moves intended to improve execution; benefits could take multiple quarters to materialize. Read More.
• Negative Sentiment: Guidance cut and margin pressure — management trimmed FY26 EPS guidance to $4.80–5.00, citing inflation, higher component and freight costs and supply issues; this is the core reason for recent downside pressure. Read More.
• Negative Sentiment: Mixed Q1 results — revenue beat (~$5.13B) but EPS missed ($0.99 vs. $1.07 est.) and margins compressed, reinforcing short‑term risk to earnings. Read More.
• Negative Sentiment: Analyst downgrades / price‑target cuts — Citigroup, JPMorgan and others trimmed targets and ratings (e.g., PTs cut to ~$65–75), pulling sell‑side support lower and contributing to volatility. Read More.
• Negative Sentiment: Investor litigation inquiry — a Johnson Fistel investigation adds headline and legal risk that could increase volatility. Read More.

GE HealthCare Technologies Price Performance

Shares of GEHC opened at $61.03 on Monday. The stock has a market cap of $27.76 billion, a price-to-earnings ratio of 14.60, a P/E/G ratio of 1.37 and a beta of 0.75. The company has a 50-day moving average price of $73.28 and a two-hundred day moving average price of $77.60. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. GE HealthCare Technologies Inc. has a 12 month low of $58.75 and a 12 month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter last year, the firm posted $1.01 EPS. The business's revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities analysts predict that GE HealthCare Technologies Inc. will post 4.88 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be paid a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies's payout ratio is 3.35%.

Analyst Ratings Changes

A number of brokerages have commented on GEHC. Bank of America raised their price target on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a "neutral" rating in a research note on Monday, January 5th. The Goldman Sachs Group cut shares of GE HealthCare Technologies from a "buy" rating to a "neutral" rating and cut their price target for the stock from $81.00 to $65.00 in a research note on Thursday. UBS Group cut shares of GE HealthCare Technologies from a "neutral" rating to a "sell" rating and raised their price target for the stock from $73.00 to $77.00 in a research note on Thursday, January 15th. Evercore set a $80.00 price target on shares of GE HealthCare Technologies in a research note on Thursday. Finally, Piper Sandler cut their price target on shares of GE HealthCare Technologies from $96.00 to $88.00 and set an "overweight" rating for the company in a research note on Friday, April 17th. Eight equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $80.67.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.